-transparent.png){kind=logo}
The metabolism and absorption of a potential new drug, Chinoin 123, having an antiatherogenic effect, were studied in rats. Using different methods it was confirmed that the main metabolite of the drug is a free acid form, formed by ester hydrolysis. In Sartorius Resorption Model only the gastric absorption was confirmed and calculated. In vivo experiments in rats showed rather good absorption. The blood and urine concentrations of the drug were determined.
Related Publications
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1982,
International archives of allergy and applied immunology,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
September 1983,
Acta pharmaceutica Hungarica,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1986,
Acta medica Hungarica,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
March 1995,
Biulleten' eksperimental'noi biologii i meditsiny,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1989,
Acta pharmaceutica Hungarica,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
November 2003,
Die Pharmazie,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1979,
Arzneimittel-Forschung,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1978,
Arzneimittel-Forschung,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
January 1985,
Acta pharmaceutica Hungarica,
P Szentmiklósi, and
S Marton, and
M Kovács, and
L Gyarmati
September 2021,
International journal of molecular sciences,
